Steve Finikiotis Email and Phone Number
Co Founder And Managing Partner
at
South Point
Steve Finikiotis's email is steve.finikiotis@ospreyvision.com
and
Steve Finikiotis's phone number is +1312-546-6600
.
Steve Finikiotis Contact Details
Email
steve.finikiotis@ospreyvision.com
Email
steve.finikiotis@so-point.com
Phone
+1312-546-6600
Steve Finikiotis Company Details
Company
Location
Johannesburg, Gauteng, South Africa
Website
Industry
Real Estate
Steve Finikiotis's Current Company
South Point
Industry | Real Estate | |
Location | Johannesburg, Gauteng, South Africa |
Industry | Real Estate | |
Location | Johannesburg, Gauteng, South Africa |
Steve Finikiotis's Experience and Education
Frequently Asked Questions about Steve Finikiotis
What company does Steve Finikiotis work for?
Steve Finikiotis works for South Point
What is Steve Finikiotis's role in his workplace?
Steve Finikiotis's role in his workplace is
Co Founder And Managing Partner .
Which industry does Steve Finikiotis work in currently?
Steve Finikiotis works in the industry
Real Estate.
What is Steve Finikiotis's email address?
Steve Finikiotis's email address is steve.finikiotis@ospreyvision.com
What is Steve Finikiotis's direct phone number?
Steve Finikiotis's direct phone number is +1312-546-6600
What are some of Steve Finikiotis's skills?
Steve Finikiotis has skills like
Leadership,
International Business,
Public Speaking,
Global Strategy,
Start Ups,
Web Design,
Blogging,
Business Analysis,
Market Research,
Competitive Analysis,
Process Improvement,
Strategic Planning,
Global Marketing,
Fundraising,
Strategy,
Business Planning,
Operations Management,
Entrepreneurship,
Program Management,
Risk Management,
and
Marketing.
Who are Steve Finikiotis's colleagues?
Steve Finikiotis's colleagues are
Khanyisa Mqikela,
Kimberly Night,
Carla Srone,
Michael Burch,
Gladys Urbano,
Aveek Banerjee,
and
Marchello Messiah.
Who are Steve Finikiotis's peers at other companies?
Steve Finikiotis's peers at other companies are
Gai Spann,
Philipp Piaz,
Simon Thackway,
Connect Pharma,
Susan Gellert,
Jonathan Kaylor,
and
Shaheen Yazdani.